oral semaglutide versus injection TrimRX Now that oral semaglutide (#wegovy)

GLP-1 receptor agonists are authorised for the treatment of diabetes 1 or for weight management under certain conditions 2 or both 3

ISMP Medication Safety Alert, 24(3), 1-6

Maritime Pine Bark Extract

Additionally, incretin therapies can have overbearing negative side effects including hypoglycaemia (often in combination with other glucose-lowering treatments), nausea, vomiting, gastrointestinal upset (including diarrhoea) and injection site reactions that contribute to therapy discontinuation ( TABLE 1 Incretin therapy studies including percentage of participants who failed to reach the desired endpoint

Olympia ti M